Moderna Inc. Stock Advances 9.9%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Moderna Inc. rallied 9.9% to $154.27 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.0% to 26,099.77 and Dow Jones Industrial Average falling 0.8% to 52,766.88.

This was the stock's second consecutive day of gains.

Moderna Inc. closed 12.7% short of its 52-week high of $176.66, which the company achieved on August 19th.

The stock outperformed some of its peers, as Johnson & Johnson rose 2.0% to $271.19, Pfizer Inc. rose 0.3% to $28.55, and Gilead Sciences Inc. rose 2.45% to $149.92.

Trading volume totaled 25.3 million, compared to the 50-day average of 16.8 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 01, 2026 16:33 ET (20:33 GMT)